Clinical Trial Update: Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating induction therapy with cytarabine, high-dose mitoxantrone, and dasatinib for Philadelphia chromosome-positive acute lymphoblastic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• DASATINIB (Dasatinib)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED